Visby Medical™ Secures Landmark De Novo FDA Approval for OTC STI Test Read more

Case Studies

Detailed accounts of clinical and patient outcomes with Visby Medical use-cases.

January 18, 2024

A case of undertreatment associated with syndromic management of STIs.

January 17, 2024

A case of overtreatment associated with syndromic management of STIs.

January 16, 2024

A case of undertreatment associated with syndromic management of STIs

January 15, 2024

A case of overtreatment associated with syndromic management of STIs

Headquarters

3010 North First Street
San Jose, CA 95134

Connect